Modulight (MODU) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Dec, 2025Executive summary
Q4 revenue grew 40% year-over-year to EUR 1.43 million, with the PPT business model expanding to 50 hospitals, mainly in the U.S., and new geographies and indications.
Order collection accelerated, reaching EUR 3.5 million in Q4, with a positive trend continuing into the new year.
EBITDA loss narrowed by 66% year-over-year in Q4, driven by lower non-recurring costs and improved operational efficiency.
Operating cash flow improved by 145% to EUR 819 thousand in Q4, despite increased R&D and sales investments.
Major investment program completed, leading to lower capital expenditures and improved cash flow.
Financial highlights
Q4 2024 revenue: EUR 1,431 thousand (+40% YoY, +123% QoQ); full-year revenue: EUR 4,095 thousand (+2%).
Q4 EBITDA: EUR -1,023 thousand (improved from -2,992k); FY24 EBITDA: EUR -4,836 thousand (improved from -8,539k).
Q4 EBIT: EUR -2,204 thousand; FY24 EBIT: EUR -8,337 thousand.
Q4 operating cash flow: EUR 819 thousand; FY24: EUR -825 thousand.
Cash and cash equivalents at year-end: EUR 17.4 million; net debt: EUR -12.9 million; equity ratio: 87.5%.
Outlook and guidance
Most customer projects remain in early development, focused on commercializing own products and expanding the PPT model.
No formal revenue or profitability outlook for 2025 due to project unpredictability and macroeconomic/geopolitical uncertainties.
Growth in the number of care facilities using cloud-connected products expected to continue or accelerate in 2025.
Latest events from Modulight
- Record revenue growth and improved profitability, driven by PPT model and project expansion.MODU
Q4 202520 Feb 2026 - Q2 2024 revenue fell 13% YoY, but EBITDA loss narrowed and cash flow improved as the pipeline grew.MODU
Q2 202423 Jan 2026 - Q3 revenue up 58% YoY, EBITDA loss narrows, and PPT model and R&D pipeline expand.MODU
Q3 202419 Jan 2026 - Revenue up 52% and EBITDA up 56%, driven by US growth and pay-per-treatment expansion.MODU
Q1 202524 Dec 2025 - Q2 revenue doubled and EBITDA neared zero as the pipeline and global customer base expanded.MODU
Q2 202523 Nov 2025 - Revenue up 176% YoY, losses narrowing, and PPT business driving strong operational gains.MODU
Q3 202531 Oct 2025